From natural disasters to global pandemics, manufacturing is prone to disruption. In recent years, prominent disruptions such as Y2K, SARS, Ebola, COVID-19, flood, drought, fires, tornados and earthquakes have all had serious impacts on the ability to deliver goods to consumers.
After the current coronavirus pandemic began impacting our reality, there have been dozens of articles on Risk Mitigation and Business Continuity. This attention has been very helpful in creating a risk-based culture, but guidance on how the process fits together and what tools to apply has been lacking.
In this workshop, we will discuss a robust risk management process that the instructor has used with GlaxoSmithKline and Pfizer when he managed their risk management planning.